Biotech hot picks highlight stocks focused on lung disease, neurological disorders and rare conditions, with growth driven by ...

BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Non-opioid analgesic shows efficacy in several animal pain models, including diabetic and chemotherapy-induced neuropathic ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

Genscript Biotech ( ($HK:1548) ) has shared an update. Genscript Biotech Corporation announced the grant of 36,314 share awards to two independent ...

This ASX biotech stock has caught my eye this year. The post Forget CSL shares, I'd buy this booming biotech stock instead ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Also on Thursday, Zealand held its Capital Markets Day in London, outlining the strategy for its weight management franchise ...

Under the TCR-antigen data licensing agreement, Adaptive will receive an upfront payment and additional future potential annual licensing fees under this non-exclusive, multi-year data access ...

Don't be too quick to jump on this biotech bandwagon.